Wound care management involves dressings, equipment, and other aids, such as bandages, gels, and ostomy drainage bags, designed to prevent and treat wounds, as well as to promote or accelerate wound healing. Topical Absorbable Hemostats are agents used to promote and accelerate hemostasis to control bleeding in cases where application of pressure, ligature, and other conventional methods are ineffective. GlobalData uses proprietary data and analytics to provide a comprehensive report on the topical absorbable hemostats market in Australia. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the topical absorbable hemostats market in Australia was Ethicon followed by Teleflex, B. Braun Melsungen, CR Bard, Gelita Medical, Medtronic and Pfizer.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Topical Absorbable Hemostats are inserted to remove excess blood, thereby preventing further bleeding and clearing up the operating site for the surgeon. Topical Absorbable Hemostats products are often plant or gelatin based and act as mechanical barriers and/or help with vasoconstriction and serve as a platform for platelet aggregation to slow the flow of blood and give the patient's body time to form a clot. Flowable Hemostats or Fibrin Sealants are tracked under the Tissue Sealants and Adhesives market. Hemostats include Active Hemostats (thrombin-based hemostats), and Combination and Passive Hemostats (oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, polysaccharide-based hemostats, collagen-based hemostats). Oxidized regenerated cellulose-based hemostats are poly anions that contain polyanhydroglucuronic acid as a functional unit to aid in the platelet adhesion and aggregation process resulting in coagulation. Gelatin is a protein developed by denaturing the collagen and polymerizing with nitrogen to produce a porous scaffold. Polysaccharide based hemostats are purified plant derived starch. Collagen is a protein derived from animal source.
The topical absorbable hemostats market in Australia can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size topical absorbable hemostats in Australia, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
